Figure 4
Comparison of the treatment effect of active vs. placebo procedures for binary primary outcomes. aComposite of death, myocardial infarction, repeat target lesion or percutaneous revascularization, and coronary artery bypass graft. bResponder rate was defined as a blood pressure drop ≥10 mmHg in systolic office blood pressure as a part of a composite outcome. cResponse was defined as an increase in office systolic blood pressure >35 mmHg while the baroreflex activation therapy device was turned off. BP, blood pressure; CCS, Canadian Cardiovascular Society; MACE, major adverse cardiovascular events; PFO, patent foramen oval.

Comparison of the treatment effect of active vs. placebo procedures for binary primary outcomes. aComposite of death, myocardial infarction, repeat target lesion or percutaneous revascularization, and coronary artery bypass graft. bResponder rate was defined as a blood pressure drop ≥10 mmHg in systolic office blood pressure as a part of a composite outcome. cResponse was defined as an increase in office systolic blood pressure >35 mmHg while the baroreflex activation therapy device was turned off. BP, blood pressure; CCS, Canadian Cardiovascular Society; MACE, major adverse cardiovascular events; PFO, patent foramen oval.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close